Wolverine Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Hold |
0
| – | – | – | 1570 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 1533 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 1620 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1709 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1700 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1714 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1857 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 2067 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2295 |
|
|
2021
Q3 | – | Sell |
-12,253
| Closed | -$313K | – | 2192 |
|
|
2021
Q2 | $313K | Buy |
12,253
+3,477
| +40% | +$88.8K | ﹤0.01% | 896 |
|
|
2021
Q1 | $120K | Buy |
+8,776
| New | +$120K | ﹤0.01% | 1173 |
|
|
2020
Q4 | – | Sell |
-26,470
| Closed | -$276K | – | 1676 |
|
|
2020
Q3 | $276K | Buy |
+26,470
| New | +$276K | ﹤0.01% | 664 |
|